In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen-Reference-Cited by-同舟云学术

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

Published:2017-02-13 Issue:6 Volume:72 Page:1709-1713
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Nishikawa Hiroshi¹,Fukuda Yoshiko¹,Mitsuyama Junichi¹,Tashiro Masato²,Tanaka Akitaka³,Takazono Takahiro²,Saijo Tomomi⁴,Yamamoto Kazuko³⁴,Nakamura Shigeki⁵,Imamura Yoshifumi⁴,Miyazaki Taiga²⁴,Kakeya Hiroshi⁶,Yamamoto Yoshihiro⁷,Yanagihara Katsunori⁸,Mukae Hiroshi⁴⁹,Kohno Shigeru⁴⁹,Izumikawa Koichi²

Affiliation:

1. Research Laboratories, Toyama Chemical Co., Ltd, 2-4-1 Shimookui, Toyama, Japan

2. Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

3. Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan

4. Second Department of Internal Medicine, Nagasaki University Hospital, Nagasaki, Japan

5. Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan

6. Department of Infection Control Science, Graduate School of Medicine, Osaka City University, Osaka, Japan

7. Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan

8. Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

9. Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Funder

NIH

Toyama Chemical Co., Ltd

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/6/1709/24331981/dkx020.pdf

Reference19 articles.